CNMD
Price
$49.37
Change
+$2.26 (+4.80%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
1.41B
6 days until earnings call
Intraday BUY SELL Signals
NVST
Price
$23.97
Change
+$0.78 (+3.36%)
Updated
Oct 22, 04:59 PM (EDT)
Capitalization
3.72B
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNMD vs NVST

CNMD vs NVST Comparison Chart in %
View a ticker or compare two or three
VS
CNMD vs. NVST commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNMD is a Buy and NVST is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CNMD with price predictions
Oct 22, 2026

CNMD in upward trend: price rose above 50-day moving average on October 22, 2026

CNMD moved above its 50-day moving average on October 22, 2026 date and that indicates a change from a downward trend to an upward trend. In 32 of 46 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CNMD's RSI Indicator exited the oversold zone, 27 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 64%.

The Momentum Indicator moved above the 0 level on October 20, 2026. You may want to consider a long position or call options on CNMD as a result. In 53 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.

The Moving Average Convergence Divergence (MACD) for CNMD just turned positive on October 15, 2026. Looking at past instances where CNMD's MACD turned positive, the stock continued to rise in 31 of 46 cases over the following month. The odds of a continued upward trend are 67%.

Following a +2.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNMD advanced for three days, in 202 of 295 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The 10-day moving average for CNMD crossed bearishly below the 50-day moving average on September 18, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 13 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

CNMD broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CNMD entered a downward trend on October 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 42 (best 1 - 100 worst), indicating steady price growth. CNMD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 60 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.355) is normal, around the industry mean (2.874). P/E Ratio (25.465) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (11.052). Dividend Yield (0.017) settles around the average of (0.009) among similar stocks. P/S Ratio (1.055) is also within normal values, averaging (40.124).

The Tickeron SMR rating for this company is 81 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CNMD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for NVST with price predictions
Oct 22, 2026

NVST's RSI Indicator climbs out of oversold territory

The RSI Indicator for NVST moved out of oversold territory on October 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 27 similar instances when the indicator left oversold territory. In 19 of the 27 cases the stock moved higher. This puts the odds of a move higher at 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on NVST as a result. In 69 of 107 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 64%.

The Moving Average Convergence Divergence (MACD) for NVST just turned positive on October 06, 2026. Looking at past instances where NVST's MACD turned positive, the stock continued to rise in 34 of 51 cases over the following month. The odds of a continued upward trend are 67%.

Following a +4.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where NVST advanced for three days, in 176 of 273 cases, the price rose further within the following month. The odds of a continued upward trend are 64%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVST declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 70%.

NVST broke above its upper Bollinger Band on October 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for NVST entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. NVST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.211) is normal, around the industry mean (4.961). P/E Ratio (39.305) is within average values for comparable stocks, (37.232). Projected Growth (PEG Ratio) (0.020) is also within normal values, averaging (4.143). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (1.451) is also within normal values, averaging (56.876).

The Tickeron PE Growth Rating for this company is 82 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
CNMD vs NVST: Fundamental Ratings
CNMD
NVST
OUTLOOK RATING
1..100
1681
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8187
PRICE GROWTH RATING
1..100
4258
P/E GROWTH RATING
1..100
682
SEASONALITY SCORE
1..100
8550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNMD's Valuation (60) in the Medical Specialties industry is in the same range as NVST (63) in the null industry. This means that CNMD’s stock grew similarly to NVST’s over the last 12 months.

CNMD's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as NVST (100) in the null industry. This means that CNMD’s stock grew similarly to NVST’s over the last 12 months.

CNMD's SMR Rating (81) in the Medical Specialties industry is in the same range as NVST (87) in the null industry. This means that CNMD’s stock grew similarly to NVST’s over the last 12 months.

CNMD's Price Growth Rating (42) in the Medical Specialties industry is in the same range as NVST (58) in the null industry. This means that CNMD’s stock grew similarly to NVST’s over the last 12 months.

CNMD's P/E Growth Rating (6) in the Medical Specialties industry is significantly better than the same rating for NVST (82) in the null industry. This means that CNMD’s stock grew significantly faster than NVST’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNMDNVST
RSI
ODDS (%)
Bullish Trend 1 day ago
64%
Bullish Trend 1 day ago
70%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
79%
Momentum
ODDS (%)
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
67%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
63%
Bearish Trend 1 day ago
72%
Advances
ODDS (%)
Bullish Trend 10 days ago
68%
Bullish Trend 1 day ago
64%
Declines
ODDS (%)
Bearish Trend 4 days ago
81%
Bearish Trend 4 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
71%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
79%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CNMD: $47.11 vs. NVST: $23.19)
Brand notoriety: CNMD and NVST are both not notable
CNMD represents the Medical/Nursing Services, while NVST is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CNMD: 125% vs. NVST: 196%
Market capitalization -- CNMD: $1.41B vs. NVST: $3.72B
CNMD [@Medical/Nursing Services] is valued at $1.41B. NVST’s [@Pharmaceuticals: Other] market capitalization is $3.72B. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $156.8B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $9.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNMD’s FA Score shows that 1 FA rating(s) are green while NVST’s FA Score has 0 green FA rating(s).

  • CNMD’s FA Score: 1 green, 4 red.
  • NVST’s FA Score: 0 green, 5 red.
According to our system of comparison, CNMD is a better buy in the long-term than NVST.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNMD’s TA Score shows that 4 TA indicator(s) are bullish while NVST’s TA Score has 6 bullish TA indicator(s).

  • CNMD’s TA Score: 4 bullish, 5 bearish.
  • NVST’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, NVST is a better buy in the short-term than CNMD.

Price Growth

CNMD (@Medical/Nursing Services) experienced а +4.85% price change this week, while NVST (@Pharmaceuticals: Other) price change was +1.62% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.74%. For the same industry, the average monthly price growth was -3.62%, and the average quarterly price growth was +9.09%.

Reported Earning Dates

CNMD is expected to report earnings on Oct 28, 2026.

NVST is expected to report earnings on Nov 04, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (+0.74% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
CNMD
Daily Signal:
Gain/Loss:
NVST
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CNMD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNMD has been loosely correlated with NVST. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CNMD jumps, then NVST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNMD
1D Price
Change %
CNMD100%
+4.95%
NVST - CNMD
49%
Loosely correlated
+3.36%
KIDS - CNMD
49%
Loosely correlated
+3.65%
IART - CNMD
48%
Loosely correlated
+4.10%
ENOV - CNMD
47%
Loosely correlated
+3.75%
ZBH - CNMD
46%
Loosely correlated
+4.16%
More

NVST and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVST has been closely correlated with ALGN. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NVST jumps, then ALGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVST
1D Price
Change %
NVST100%
+3.36%
ALGN - NVST
70%
Closely correlated
+2.74%
XRAY - NVST
60%
Loosely correlated
+4.63%
BIO - NVST
57%
Loosely correlated
+0.83%
A - NVST
55%
Loosely correlated
-2.17%
MTD - NVST
52%
Loosely correlated
+0.40%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AN161.848.83
+5.77%
AutoNation
CLVT1.850.09
+5.11%
Clarivate Plc
LCTX0.990.03
+3.52%
Lineage Cell Therapeutics
CRWS2.420.07
+2.98%
Crown Crafts
CNI124.932.88
+2.36%
Canadian National Railway